Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Bishop

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphomaZ S Pavletic, P J Bierman, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignanciesD L Darrington, J M Vose, J R Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Journal of Clinical Microbiology|September 10, 2010
Death by edible mushroom: first report of Volvariella volvacea as an etiologic agent of invasive disease in a patient following double umbilical cord blood transplantationR B Salit, Y R Shea, J Gea-Banacloche, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Leukemia|March 21, 2003
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002P M Navolanic, C-H Pui, R A Larson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 8, 2008
Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantationM R Bishop, R M Dean, S M Steinberg, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Journal of Hematotherapy|November 22, 1997
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndromeM R Bishop, J D Jackson, S R Tarantolo, et al.
Bone Marrow Transplantation|June 9, 2015
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipientsP Y Yew, H Alachkar, R Yamaguchi, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphomaZ S Pavletic, P J Bierman, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignanciesD L Darrington, J M Vose, J R Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Journal of Clinical Microbiology|September 10, 2010
Death by edible mushroom: first report of Volvariella volvacea as an etiologic agent of invasive disease in a patient following double umbilical cord blood transplantationR B Salit, Y R Shea, J Gea-Banacloche, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Leukemia|March 21, 2003
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002P M Navolanic, C-H Pui, R A Larson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 8, 2008
Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantationM R Bishop, R M Dean, S M Steinberg, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Journal of Hematotherapy|November 22, 1997
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndromeM R Bishop, J D Jackson, S R Tarantolo, et al.
Bone Marrow Transplantation|June 9, 2015
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipientsP Y Yew, H Alachkar, R Yamaguchi, et al.
Pageof 8